No significant strengths identified
| Name | Market Cap | Current Price | P/E Ratio | Revenue Growth 1Y | Net Margin | ROE | FCF Yield | Debt/Equity |
|---|---|---|---|---|---|---|---|---|
| TECHBio-Techne Corporation | 10.9B | 69.96 | 152.09 | 5.23% | 6.41% | 3.97% | 2.35% | 0.23 |
| SPRYARS Pharmaceuticals, Inc. | 1.1B | 11.09 | 142.00 | 2970.63% | -56.06% | -54.21% | 1.18% | 0.00 |
| VCYTVeracyte, Inc. | 3.24B | 41.00 | 132.26 | 23.46% | 6.12% | 2.41% | 1.97% | 0.04 |
| CSBRChampions Oncology, Inc. | 99.56M | 7.17 | 21.73 | 13.54% | 4.32% | 59.65% | 7.03% | 1.62 |
| MDXGMiMedx Group, Inc. | 851.59M | 5.75 | 20.54 | 8.52% | 10.38% | 17.09% | 7.58% | 0.13 |
| LTRNLantern Pharma Inc. | 39.26M | 3.51 | -0.00 | -197.36% | 0.01 | |||
| SEERSeer, Inc. | 107.44M | 1.91 | -1.37 | -8.13% | -486.02% | -29.19% | 0.08 | |
| IMDXInsight Molecular Diagnostics Inc. | 189.76M | 6.62 | -1.42 | 25.15% | -13.81% | -14.81% |
| Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 0 | 0 | 0 | 0 | 105.03K | 933.72K | 645.18K | 133.99K |
| Revenue Growth % | - | - | - | - | - | 7.89% | -0.31% | -0.79% |
| Cost of Goods Sold | 0 | 0 | 0 | 17.77K | 77.98K | 766.78K | 756.84K | 627.47K |
| COGS % of Revenue | - | - | - | - | 0.74% | 0.82% | 1.17% | 4.68% |
| Gross Profit | 0 | 0 | 0 | -17.77K | 27.05K | 166.94K | -111.66K | -493K |
| Gross Margin % | - | - | - | - | 0.26% | 0.18% | -0.17% | -3.68% |
| Gross Profit Growth % | - | - | - | - | 2.52% | 5.17% | -1.67% | -3.42% |
| Operating Expenses | 212.99K | 5.61M | 5.87M | 8.85M | 41.96M | 25.65M | 25.95M | 27.37M |
| OpEx % of Revenue | - | - | - | - | 399.51% | 27.47% | 40.22% | 204.28% |
| Selling, General & Admin | 212.99K | 5.08M | 5.7M | 7.92M | 22.42M | 17.84M | 18.88M | 16.48M |
| SG&A % of Revenue | - | - | - | - | 213.45% | 19.1% | 29.26% | 123.03% |
| Research & Development | 0 | 525K | 175.44K | 937.97K | 5.04M | 7.27M | 7.07M | 10.89M |
| R&D % of Revenue | - | - | - | - | 48.01% | 7.78% | 10.96% | 81.25% |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 14.5M | 544.03K | 0 | 0 |
| Operating Income | -213K | -5.61M | -5.87M | -8.87M | -41.94M | -25.48M | -26.06M | -27.86M |
| Operating Margin % | - | - | - | - | -399.25% | -27.29% | -40.4% | -207.96% |
| Operating Income Growth % | - | -25.33% | -0.05% | -0.51% | -3.73% | 0.39% | -0.02% | -0.07% |
| EBITDA | 638.94K | 0 | 0 | -8.85M | -41.46M | -24.94M | -25.52M | -27.25M |
| EBITDA Margin % | - | - | - | - | -394.72% | -26.71% | -39.55% | -203.36% |
| EBITDA Growth % | - | -1% | - | - | -3.68% | 0.4% | -0.02% | -0.07% |
| D&A (Non-Cash Add-back) | 851.94K | 5.61M | 5.87M | 17.77K | 476.24K | 535.98K | 542.58K | 617.25K |
| EBIT | -213K | -5.61M | -5.83M | -8.84M | -44.43M | -25.36M | -26M | -27.66M |
| Net Interest Income | 0 | 0 | 0 | -309.52K | -1.94M | -2.23M | -6.38M | -7.36M |
| Interest Income | 0 | 0 | 1.93K | 563 | 3.1K | 57.35K | 10.17K | 1.45K |
| Interest Expense | 0 | 79.77K | 1.93K | 310.08K | 1.94M | 2.29M | 6.39M | 7.36M |
| Other Income/Expense | 0 | -79.77K | 43.07K | -277.02K | -4.44M | -2.17M | -6.33M | -7.16M |
| Pretax Income | -852K | -5.69M | -5.83M | -9.15M | -46.37M | -27.65M | -32.39M | -35.02M |
| Pretax Margin % | - | - | - | - | -441.49% | -29.61% | -50.2% | -261.37% |
| Income Tax | -852K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0.25% | 1% | 1% | 1% | 1% | 1% | 1% | 0.98% |
| Net Income | -213K | -5.69M | -5.83M | -9.15M | -46.37M | -27.65M | -32.38M | -34.45M |
| Net Margin % | - | - | - | - | -441.49% | -29.61% | -50.19% | -257.09% |
| Net Income Growth % | - | -25.71% | -0.02% | -0.57% | -4.07% | 0.4% | -0.17% | -0.06% |
| Net Income (Continuing) | -213K | -5.69M | -5.83M | -9.15M | -46.37M | -27.65M | -32.39M | -35.02M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | -9.61K | -583.18K |
| EPS (Diluted) | -999999.00 | -999999.00 | -999999.00 | -999999.00 | -999999.00 | -999999.00 | -999999.00 | -346053.00 |
| EPS Growth % | - | -25.71% | -0.02% | 0.37% | -2.44% | 0.88% | 0.82% | 1% |
| EPS (Basic) | -999999.00 | -999999.00 | -999999.00 | -999999.00 | -999999.00 | -999999.00 | -999999.00 | -346053.00 |
| Diluted Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 117 |
| Basic Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 117 |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - |
| Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 25K | 115.71K | 4.09K | 11.03M | 9.42M | 4.74M | 6.91M | 2M |
| Cash & Short-Term Investments | 25K | 115.71K | 4.09K | 10.5M | 7.87M | 2.77M | 97.1K | 833.03M |
| Cash Only | 25K | 115.71K | 4.09K | 10.5M | 7.87M | 2.77M | 97.1K | 833.03K |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 832.2M |
| Accounts Receivable | 0 | 0 | 0 | 0 | 589.84K | 527.96K | 5.85M | 1.15M |
| Days Sales Outstanding | - | - | - | - | 2.05K | 206.39 | 3.31K | 3.14K |
| Inventory | 0 | 0 | 0 | 0 | 494.7K | 950.09K | 745.5K | 11.24K |
| Days Inventory Outstanding | - | - | - | - | 2.32K | 452.26 | 359.53 | 6.54 |
| Other Current Assets | 0 | 0 | 0 | 384.69K | 0 | 0 | 0 | -885.71M |
| Total Non-Current Assets | 0 | 0 | 119.44K | 2.06M | 7.25M | 5.99M | 37.67M | 30.14M |
| Property, Plant & Equipment | 0 | 0 | 0 | 1.67M | 6.36M | 5.48M | 4.1M | 2.77M |
| Fixed Asset Turnover | - | - | - | - | 0.02x | 0.17x | 0.16x | 0.05x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 321K | 214K | 107K | 9.44K | 6.11K |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 22.28M | 27.28M |
| Other Non-Current Assets | 0 | 0 | 119.44K | 72.3K | 668.79K | 405.37K | 11.28M | -310.19K |
| Total Assets | 25K | 115.71K | 123.53K | 13.1M | 16.66M | 10.74M | 44.58M | 32.14M |
| Asset Turnover | - | - | - | - | 0.01x | 0.09x | 0.01x | 0.00x |
| Asset Growth % | - | 3.63% | 0.07% | 105.02% | 0.27% | -0.36% | 3.15% | -0.28% |
| Total Current Liabilities | 59.9K | 1.65M | 2.98M | 1.23M | 3.61M | 3.64M | 25.89M | 23.41M |
| Accounts Payable | 8.57K | 1.06M | 1.85M | 241.61K | 1.58M | 1.96M | 8.55M | 10.19M |
| Days Payables Outstanding | - | - | - | 4.96K | 7.37K | 932.28 | 4.13K | 5.93K |
| Short-Term Debt | 0 | 163.6K | 165.6K | 587.59K | 700.43K | 409.98K | 16.18M | 5.8M |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | -1000K | -1000K | 0 | 0 |
| Other Current Liabilities | 51.33K | 0 | 0 | 6.54K | 1.76M | 2.15M | 158.61K | 4.48M |
| Current Ratio | 0.42x | 0.07x | 0.00x | 8.99x | 2.61x | 1.30x | 0.27x | 0.09x |
| Quick Ratio | 0.42x | 0.07x | 0.00x | 8.99x | 2.47x | 1.04x | 0.24x | 0.08x |
| Cash Conversion Cycle | - | - | - | - | -3.01K | -273.63 | -455.04 | -2.78K |
| Total Non-Current Liabilities | 25K | 1.22M | 0 | 858.06K | 2.88M | 1.89M | 2.64M | 450.87K |
| Long-Term Debt | 0 | 0 | 0 | 0 | 110.04K | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 0 | 858.06K | 2.77M | 1.89M | 1.04M | 436.35K |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 25K | 0 | 0 | 0 | 0 | 0 | 1.6M | 14.52K |
| Total Liabilities | 84.9K | 1.65M | 2.98M | 2.09M | 6.48M | 5.53M | 28.53M | 23.86M |
| Total Debt | 0 | 163.6K | 165.6K | 1.84M | 4.72M | 3.38M | 18.22M | 6.92M |
| Net Debt | -25K | 47.89K | 161.51K | -8.66M | -3.15M | 613.22K | 18.12M | 6.09M |
| Debt / Equity | - | - | - | 0.17x | 0.46x | 0.65x | 1.14x | 0.84x |
| Debt / EBITDA | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | -0.04x | - | - | - | - | - | - | - |
| Interest Coverage | - | -70.32x | -3041.86x | -28.61x | -21.63x | -11.15x | -4.08x | -3.78x |
| Total Equity | -59.9K | -1.54M | -2.85M | 11.01M | 10.18M | 5.21M | 16.05M | 8.29M |
| Equity Growth % | - | -24.65% | -0.86% | 4.86% | -0.08% | -0.49% | 2.08% | -0.48% |
| Book Value per Share | - | - | - | 0.85 | 0.23 | 1.21 | 12.17 | 71060.39 |
| Total Shareholders' Equity | -59.9K | -1.54M | -2.85M | 11.01M | 10.18M | 5.21M | 16.06M | 8.87M |
| Common Stock | 7.1K | 7.53K | 3.92K | 13.08K | 44.53K | 4.31K | 1.32K | 130 |
| Retained Earnings | -212.99K | -5.9M | -11.73M | -20.88M | -67.35M | -95.04M | -127.74M | -168.09M |
| Treasury Stock | 0 | 0 | -189.63K | -201.6K | -201.6K | -201.6K | -201.6K | -201.6K |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | -9.61K | -583.18K |
| Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|
| Cash from Operations | 0 | -386.26K | -464.35K | -7.22M | -22.28M | -22.39M | -18.58M | -16.76M |
| Operating CF Margin % | - | - | - | - | -212.1% | -23.98% | -28.79% | -125.1% |
| Operating CF Growth % | - | - | -0.2% | -14.55% | -2.09% | -0.01% | 0.17% | 0.1% |
| Net Income | -851.94K | -5.69M | -5.83M | -9.15M | -46.37M | -27.65M | -32.38M | -34.45M |
| Depreciation & Amortization | 0 | 0 | 0 | 17.77K | 476.24K | 535.98K | 542.58K | 617.25K |
| Stock-Based Compensation | 612.34K | 3.52M | 4.23M | 3.19M | 4.64M | 3.13M | 1.4M | 6.75M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 17M | 0 | 0 | 0 |
| Other Non-Cash Items | 34.26K | 350.51K | 0 | 300K | 1.85M | 2.08M | 2.76M | 3.23M |
| Working Capital Changes | 205.34K | 1.43M | 1.13M | -1.58M | 129.97K | -493.44K | 9.1M | 7.09M |
| Change in Receivables | 0 | 0 | 0 | 0 | -89.84K | -36.77K | 119.64K | 364.89K |
| Change in Inventory | 0 | 0 | 0 | 0 | -494.7K | -455.4K | 204.59K | 734.26K |
| Change in Payables | 0 | 1.05M | 601.61K | -1.48M | 1.33M | 412.96K | 6.65M | 5.1M |
| Cash from Investing | 0 | 0 | 0 | -170.63K | -16.31M | -241.92K | -14.41K | -5M |
| Capital Expenditures | 0 | 0 | 0 | -170.63K | -1.02M | -367.08K | -14.41K | 0 |
| CapEx % of Revenue | - | - | - | - | 9.67% | 0.39% | 0.02% | - |
| Acquisitions | - | - | - | - | - | - | - | - |
| Investments | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | -15.29M | 125.16K | 0 | 0 |
| Cash from Financing | 100K | 476.97K | 352.73K | 17.89M | 35.95M | 17.53M | 16.55M | 22.5M |
| Debt Issued (Net) | - | - | - | - | - | - | - | - |
| Equity Issued (Net) | - | - | - | - | - | - | - | - |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | - | - | - | - | - | - | - | - |
| Other Financing | 100K | -273.75K | -119.44K | -45K | 2.53M | 709.08K | 627.86K | 5.58M |
| Net Change in Cash | - | - | - | - | - | - | - | - |
| Free Cash Flow | 0 | -386.26K | -464.35K | -7.39M | -23.29M | -22.76M | -18.59M | -16.76M |
| FCF Margin % | - | - | - | - | -221.77% | -24.37% | -28.82% | -125.1% |
| FCF Growth % | - | - | -0.2% | -14.92% | -2.15% | 0.02% | 0.18% | 0.1% |
| FCF per Share | - | - | - | -0.57 | -0.52 | -5.29 | -14.10 | -143744.38 |
| FCF Conversion (FCF/Net Income) | - | 0.07x | 0.08x | 0.79x | 0.48x | 0.81x | 0.57x | 0.49x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | - | - | - | -224.26% | -437.62% | -359.39% | -304.72% | -283.12% |
| Return on Invested Capital (ROIC) | - | - | - | - | -670.76% | -297.44% | -97.77% | -86.1% |
| Gross Margin | - | - | - | - | 25.76% | 17.88% | -17.31% | -367.95% |
| Net Margin | - | - | - | - | -44148.56% | -2961.29% | -5018.92% | -25708.85% |
| Debt / Equity | - | - | - | 0.17x | 0.46x | 0.65x | 1.14x | 0.84x |
| Interest Coverage | - | -70.32x | -3041.86x | -28.61x | -21.63x | -11.15x | -4.08x | -3.78x |
| FCF Conversion | - | 0.07x | 0.08x | 0.79x | 0.48x | 0.81x | 0.57x | 0.49x |
| Revenue Growth | - | - | - | - | - | 788.96% | -30.9% | -79.23% |
Aditxt, Inc. (ADTX) reported $0.0M in revenue for fiscal year 2024.
Aditxt, Inc. (ADTX) saw revenue decline by 79.2% over the past year.
Aditxt, Inc. (ADTX) reported a net loss of $42.2M for fiscal year 2024.
Aditxt, Inc. (ADTX) has a return on equity (ROE) of -283.1%. Negative ROE indicates the company is unprofitable.
Aditxt, Inc. (ADTX) had negative free cash flow of $22.6M in fiscal year 2024, likely due to heavy capital investments.